Saturday, January 16, 2021

Week in Review: Number 1

Neurological Basis of Charles Bonnet Syndrome
This is a very interesting study both for scientific and clinical reasons. The idea to investigate spontaneous "resting-state" fluctuations in the brain via patients with Charles Bonnet syndrome is excellent. These are patients who experience visual hallucinations, "phantom vision" if you will, after losing sight. Their eyes no longer send input to their brain, but these patients can still "see" with their intact visual cortex. Of note is the finding that brain wave activity reminiscent of slow spontaneous fluctuations emerged just before onset of the hallucination, indicating that the hallucinations were evoked internally and not from external stimuli. Limitations of the study include its small sample size of only five patients with Charles Bonnet syndrome. However, the news coverage of Charles Bonnet syndrome is an excellent opportunity to call attention to this condition. As you can imagine, hallucinations can be a frightening and isolating experience. So awareness of Charles Bonnet syndrome for both trainees and the public increases assurance if they encounter the situation.

Anti-fibrotic Therapy for Glaucoma

In this study, researchers at the University of Burmingham in the U.K. investigated the use of anti-fibrotic low molecular weight dextran-sulphate (ILB) as a potential therapeutic for open-angle glaucoma (OAG) in preclinical rodent models. The researchers state, "[W]e demonstrated that ILB acts, in part, by downregulating transforming growth factor (TGF) β signaling genes and by altering gene expression relating to extracellular matrix dynamics, leading to tissue remodeling, reduced fibrosis and functional tissue regeneration. These observations indicate the potential of ILB® to alleviate fibrotic diseases." To my knowledge, that would be a novel mechanism to treat OAG by reducing fibrosis of the trabecular meshwork. A major limitation of the approach, however, is that ILB as currently formulated is delivered by daily subcutaneous injection. The researchers are planning to work on a topical "shear thinning fluid gel" as a delivery method.

Early Detection of Cognitive Decline in Type 1 Diabetics

Ocular Coherence Tomography (OCT) and its most recent additional function of angiography (OCTA) have been explored in recent years as a means of early detection of neurodegenerative diseases such as Alzheimer's. The retina, being an extension of the brain (specifically the diencephalon), allows for a unique, noninvasive, and comparatively inexpensive view into conditions that affect the central nervous system. What was new to me, i.e., what this article introduced me to, is the potential connection between diabetes and Alzheimer's disease. The researchers found associations between proliferative diabetic retinopathy (PDR) and certain memory and psychomotor tasks. The small and somewhat cloistered study, comprising 129 participants, investigated the link for people with Type 1 diabetes, but the researchers plan on future studies for the larger population of people who are affected by Type 2 diabetes.

Ultra-Thin Sensor for Smart Contact Lenses
Smart contact lenses "could soon become" mainstream for a long time now. I don't think there is actually anything exciting about this paper. Their contact lens is a prototype design, from an engineering approach, that has not progressed to testing in animal (rabbit) models yet. I suppose thin electrical components would indeed be very important for a device that would sit against a very sensitive ocular surface, but let's say that this design is still in a very early phase at this point.

In the News
An interesting read. A more experienced version of my own thoughts generally, except for the following: “I sometimes tell a patient with complex disease, ‘I’ll teach you something about your disease at every visit, and eventually you’ll have a PhD in glaucoma.’ I’ve even been known to assign homework.” This is a great joke! And I think it’s a great example to show the devaluing of doctoral degrees across the board. Just as it is a rigorous process to earn an MD, it is a rigorous process to earn a PhD. For one, a PhD requires generating new knowledge, not merely disseminating existing knowledge that (prior) PhDs have produced. I don’t want to go as far as to say that it is ironic, but this is something to be mindful of as well.

In Other News
1) Aphantasia
2) Optical illusions and dogs
3) Magnetic sense in birds

No comments:

Post a Comment